MartinaLutter.com
  • 0Shopping Cart
  • Home
  • About us
  • How we help
  • Blog
  • Shop
    • Reports
    • Terms & Conditions
  • Contact
  • Search
  • Menu

Your cart is currently empty.

Return To Shop

Recent Posts

  • Slovak life science innovations 23. May 2019
  • Biosamples storage without refrigeration; Central Europe attractive for vaccine manufacturers; Zika virus for brain tumors treatment; Mechanism of lactoferrin antitumor features 3. May 2018
  • Slovakia 2017 and the Velvet Revolution 1989 17. November 2017
  • Why I like this nonmedical “therapy” for dementia? 28. July 2017
  • New biomarkers in AD; $300m for European biotechs; Multiple sclerosis detection; Artificial intelligence 20. June 2017
  • PD drugs lost in translation; FDA vs EMA; HD code and a “heavy” pill; Regeneron´s hypercholesterolemia drug 2 7. April 2017
  • Cholesterol, Brain-computer interface, Metabolomic profiles 1. February 2017
  • Alzheimer´s Funding; $ 100 millions for start-ups; Eat fiber or be eaten; Open access policy 17. January 2017
  • Cell vaccines; AFFiRiS´ PCSK9 and PD vaccines; Pfizer´s smoking cessation vaccine 3. January 2017
  • Cell Atlas; Creutzfeldt-Jakob disease; Profitable Biotechs; Artificial intelligence; HIV 19. December 2016

Tags

approvals biomedicine blog cancer cardiovascular diseases CETP inhibitor cholesterol chronic disease comment diagnostics drug development drugs EC EMA Europe Horizon 2020 immunotherapy indications MedScan news non-infectious disease original article orphan drug pain preview of two weeks prostate cancer rare disease report research science small molecule vaccine
Our company is registered in Slovakia in the Business Register of the District Court Bratislava I under the No. 47 514 892
© 2016 martinalutter.com | Račianska 65, 831 02 Bratislava, Slovakia | E-mail: info@martinalutter.com | Disclaimer
Scroll to top